Key Metrics
CiteScore 

6.6
Eigenfactor 

0.001 - 0.005
H-Index 

54
Impact Factor 

< 5
SJR 

Q1Hepatology

SNIP 

1.42
Recommended pre-submission checks
Powered by 

Topics Covered on Gut and Liver
Gut and Liver Journal Specifications
Indexed in the following public directories
Web of Science
DOAJ
SJR
| Overview | |
| Publisher | EDITORIAL OFFICE GUT & LIVER |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2007 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Gut and Liver ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Gut and Liver
Novel Efferocytosis-Related Prognostic Signature for Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization.
- 7 May 2026
- Gut and liver
Risk of Gastric Neoplasms in Patients with Autoimmune Gastritis: A Systematic Review and Meta-Analysis.
- 6 May 2026
- Gut and liver
High Cardiometabolic Risk Burden Predicts Adverse Outcomes in Patients with MASLD-Related Hepatocellular Carcinoma.
- 6 May 2026
- Gut and liver
The Chronic Hepatitis B and Metabolic Dysfunction-Associated Steatotic Liver Disease Paradox: Friend or Foe?
- 23 Apr 2026
- Gut and liver
Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide in Chronic Hepatitis B: A Multicenter Randomized Trial in Korea.
- 22 Apr 2026
- Gut and liver
Comments on Creation of a Durable Conduit with a Novel Self-Expandable Metal Stent for Stone Extraction in Endoscopic Retrograde Cholangiopancreatography: A Pilot Study.
- 13 Apr 2026
- Gut and liver
Novel Efferocytosis-Related Prognostic Signature for Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization.
- 7 May 2026
- Gut and liver
Risk of Gastric Neoplasms in Patients with Autoimmune Gastritis: A Systematic Review and Meta-Analysis.
- 6 May 2026
- Gut and liver
High Cardiometabolic Risk Burden Predicts Adverse Outcomes in Patients with MASLD-Related Hepatocellular Carcinoma.
- 6 May 2026
- Gut and liver
The Chronic Hepatitis B and Metabolic Dysfunction-Associated Steatotic Liver Disease Paradox: Friend or Foe?
- 23 Apr 2026
- Gut and liver
Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide in Chronic Hepatitis B: A Multicenter Randomized Trial in Korea.
- 22 Apr 2026
- Gut and liver
Comments on Creation of a Durable Conduit with a Novel Self-Expandable Metal Stent for Stone Extraction in Endoscopic Retrograde Cholangiopancreatography: A Pilot Study.
- 13 Apr 2026
- Gut and liver